Abstract:OBJECTIVE:To investigate the T cell proliferative response and antibody formation to citrullinated collagen type II (Cit-CII) in patients with rheumatoid arthritis (RA), and explore whether autoreactive T cells responding to Cit-CII plays a role in the pathogenesis of RA.METHODS:Arginine residues of bovine collagen type II (CII) were converted to citrulline residues by peptidylarginine deiminase (PAD). Peripheral blood samples were collected from 34 RA patients, and 18 sex- and age-matched controls, including 6 osteoarthritis patients and 12 healthy blood donors. Peripheral blood mononuclear cells (PBMCs) were isolated and cultured with Cit-CII, CII, or fetal bovine serum RPMI 1640 fluid, phytohemagglutinin (PHA), or citrullinated buffer as controls. Cellular reactivity levels against Cit-CII and CII were investigated by measuring the proliferation of PBMCs to calculate the stimulation index (SI). ELISA was used to detect the presence of antibodies against Cit-CII and CII.RESULTS:The positive rate of T cell proliferative response to Cit-CII of the RA group was 32.4% (11/34), significantly higher than that of the control group (0, P < 0.05). The positive rate of T cell proliferative response to CII of the RA group was 35.3% (12/34), significantly higher than that of the control group (11.1%, P < 0.05). Interestingly, Cit-CII could not elicit a better T cell proliferative response than CII did. In the RA patients, the anti-Cit-CII antibody positive rate was 52.9% (18/34), significantly higher than that of the anti-CII antibody positive rate [32.4% (11/34), P < 0.05). The serum IgG anti-CII antibody positive rate of the patients with positive T cell responses to CII was 58.3% (7/12), significantly higher than that of the patients with negative T cell responses to CII [18.2% (4/22), P < 0.05]. The serum IgG anti-CII antibody positive rate of the patients with positive T cell responses to Cit-CII was 72.7% (8/11), significantly higher than that of the patients with negative T cell responses to Cit-CII [43.5% (10/23), P < 0.05].CONCLUSION:The recognition of Cit-CII by circulating IgG antibodies is a RA-specific serological phenomenon. The formation of CII antibody in the RA patients may be related to B cell activation mediated by CII specific T cells. The role of Cit-CII in RA cellular immune need be further studied.

[Proliferation of Type II Collagen Specific T Cell Response and Antibody Formation in Rheumatoid Arthritis and Their Relations to HLA-DR4].

[Relationship Between HLA-DR4/1 Subtypes and T Cell Responses to Type II Collagen or Anti-C II 263-272 Antibodies].

[T Cell Proliferative Response and Antibody Formation to Citrullinated Collagen Type II in Patients with Rheumatoid Arthritis].

[Relationship Between HLA-DR4/1 Subtypes and T Cell Response to Influenza Virus Hemagglutinin or Anti-Ha308-317 Antibodies in Rheumatoid Arthritis].

Definition of Mhc and T Cell Receptor Contacts in the Hla-Dr4-Restricted Immunodominant Epitope in Type Ii Collagen and Characterization of Collagen-Induced Arthritis in Hla-Dr4 and Human Cd4 Transgenic Mice

The Effects of HLA-DRβ1 Specific Hyporesponsive Peptide on T Cell Activation in Rheumatoid Arthritis

Enhanced T Cell Proliferative Response to Recombinant Human Type II Collagen Peptide 250-270 in Patients with Rheumatoid Arthritis

Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor

Multifunctional T Cell Reactivity to Native and Glycosylated Type-II Collagen in Rheumatoid Arthritis.

The Inhibitory Effect of the Altered Collagen II Peptide on T Cell Activation in Patients with Rheumatoid Arthritis

Association Between Protein Tyrosine Phosphatase 22 Variant R620W in Conjunction with the HLA-DRB1 Shared Epitope and Humoral Autoimmunity to an Immunodominant Epitope of Cartilage-Specific Type II Collagen in Early Rheumatoid Arthritis.

Predominant Selection of T Cells Specific for the Glycosylated Collagen Type II Epitope (263-270) in Humanized Transgenic Mice and in Rheumatoid Arthritis.

[The Study of Inhibitory Peptides on T Cell Activation in Rheumatoid Arthritis].

The HLA‐DRB1 Shared Epitope is Not Associated with Antibodies Against Cyclic Citrullinated Peptide in Chinese Patients with Rheumatoid Arthritis

Inhibition of Collagen-Induced Arthritis by HLA-DRβ1 Specific Non-T Cell Binding Peptide

A Novel Hla-Drb1*10:01-Restricted T Cell Epitope from Citrullinated Type Ii Collagen Relevant to Rheumatoid Arthritis

The Impact of Glycosylation on Hla-Dr1-Restricted T Cell Recognition of Type Ii Collagen in A Mouse Model

N-Glycosylated Type II Collagen Peptides As Therapeutic Saccharide Vaccines for Rheumatoid Arthritis

Collagen-specific Cytotoxic T Lymphocyte Responses in Patients with Ankylosing Spondylitis and Reactive Arthritis.

Class Ii Major Histocompatibility Complex-Associated Response to Type Xi Collagen Regulates the Development of Chronic Arthritis in Rats

Altered Collagen II Peptides Inhibited T-cell Activation in Rheumatoid Arthritis.